25 XP   0   0   10

Caredx Inc
Buy, Hold or Sell?

Let's analyse Caredx together

PenkeI guess you are interested in Caredx Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Caredx Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Caredx Inc

I send you an email if I find something interesting about Caredx Inc.

Quick analysis of Caredx (30 sec.)










What can you expect buying and holding a share of Caredx? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
$4.89
Expected worth in 1 year
$1.74
How sure are you?
42.5%

+ What do you gain per year?

Total Gains per Share
$-3.16
Return On Investment
-39.1%

For what price can you sell your share?

Current Price per Share
$8.07
Expected price per share
$4.8 - $12.68
How sure are you?
50%

1. Valuation of Caredx (5 min.)




Live pricePrice per Share (EOD)

$8.07

Intrinsic Value Per Share

$-20.30 - $-5.36

Total Value Per Share

$-15.41 - $-0.46

2. Growth of Caredx (5 min.)




Is Caredx growing?

Current yearPrevious yearGrowGrow %
How rich?$261.3m$442.1m-$71.9m-19.4%

How much money is Caredx making?

Current yearPrevious yearGrowGrow %
Making money-$47.5m-$19.1m-$28.4m-59.7%
Net Profit Margin-70.3%-23.8%--

How much money comes from the company's main activities?

3. Financial Health of Caredx (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#53 / 146

Most Revenue
#64 / 146

Most Profit
#131 / 146

Most Efficient
#101 / 146

What can you expect buying and holding a share of Caredx? (5 min.)

Welcome investor! Caredx's management wants to use your money to grow the business. In return you get a share of Caredx.

What can you expect buying and holding a share of Caredx?

First you should know what it really means to hold a share of Caredx. And how you can make/lose money.

Speculation

The Price per Share of Caredx is $8.07. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Caredx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Caredx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.89. Based on the TTM, the Book Value Change Per Share is $-0.79 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.19 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Caredx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-2.21-27.4%-0.89-11.0%-0.36-4.5%-0.32-3.9%-0.23-2.9%
Usd Book Value Change Per Share-2.38-29.5%-0.79-9.8%-0.19-2.4%0.151.9%0.202.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.010.1%0.020.2%
Usd Total Gains Per Share-2.38-29.5%-0.79-9.8%-0.19-2.4%0.162.0%0.212.6%
Usd Price Per Share12.00-9.16-21.73-33.57-20.29-
Price to Earnings Ratio-1.36--3.79--14.97--148.92--84.49-
Price-to-Total Gains Ratio-5.04--25.57--119.00--232.17--97.37-
Price to Book Ratio2.45-1.43-2.59-7.26--21.00-
Price-to-Total Gains Ratio-5.04--25.57--119.00--232.17--97.37-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share8.07
Number of shares123
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-0.790.15
Usd Total Gains Per Share-0.790.16
Gains per Quarter (123 shares)-97.0420.07
Gains per Year (123 shares)-388.1880.28
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-388-39857570
20-776-78611150150
30-1165-117416225230
40-1553-156222299310
50-1941-195027374390
60-2329-233833449470
70-2717-272638524550
80-3105-311444599630
90-3494-350249674710
100-3882-389054748790

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%2.038.00.05.0%2.042.03.04.3%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%8.012.00.040.0%16.023.01.040.0%17.026.04.036.2%
Dividend per Share0.00.04.00.0%1.00.011.08.3%3.00.017.015.0%8.00.032.020.0%8.00.039.017.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%8.012.00.040.0%17.023.00.042.5%18.026.03.038.3%

Fundamentals of Caredx

About Caredx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

Fundamental data was last updated by Penke on 2024-04-11 03:49:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Caredx Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Caredx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Caredx to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -180.1% means that $-1.80 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Caredx Inc:

  • The MRQ is -180.1%. The company is making a huge loss. -2
  • The TTM is -70.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-180.1%TTM-70.3%-109.8%
TTM-70.3%YOY-23.8%-46.5%
TTM-70.3%5Y-26.6%-43.8%
5Y-26.6%10Y-48.4%+21.8%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-180.1%-7.2%-172.9%
TTM-70.3%-6.3%-64.0%
YOY-23.8%1.3%-25.1%
5Y-26.6%-2.2%-24.4%
10Y-48.4%-1.4%-47.0%
1.1.2. Return on Assets

Shows how efficient Caredx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Caredx to the Diagnostics & Research industry mean.
  • -24.4% Return on Assets means that Caredx generated $-0.24 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Caredx Inc:

  • The MRQ is -24.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-24.4%TTM-9.6%-14.8%
TTM-9.6%YOY-3.5%-6.1%
TTM-9.6%5Y-4.1%-5.5%
5Y-4.1%10Y-7.5%+3.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.4%-1.5%-22.9%
TTM-9.6%-1.2%-8.4%
YOY-3.5%-0.6%-2.9%
5Y-4.1%-0.6%-3.5%
10Y-7.5%-0.9%-6.6%
1.1.3. Return on Equity

Shows how efficient Caredx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Caredx to the Diagnostics & Research industry mean.
  • -45.2% Return on Equity means Caredx generated $-0.45 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Caredx Inc:

  • The MRQ is -45.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -15.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-45.2%TTM-15.7%-29.5%
TTM-15.7%YOY-4.3%-11.4%
TTM-15.7%5Y-6.0%-9.7%
5Y-6.0%10Y-14.1%+8.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-45.2%-0.5%-44.7%
TTM-15.7%--15.7%
YOY-4.3%0.3%-4.6%
5Y-6.0%-1.5%-4.5%
10Y-14.1%-2.5%-11.6%

1.2. Operating Efficiency of Caredx Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Caredx is operating .

  • Measures how much profit Caredx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Caredx to the Diagnostics & Research industry mean.
  • An Operating Margin of -36.4% means the company generated $-0.36  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Caredx Inc:

  • The MRQ is -36.4%. The company is operating very inefficient. -2
  • The TTM is -36.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-36.4%TTM-36.9%+0.5%
TTM-36.9%YOY-24.0%-12.9%
TTM-36.9%5Y-20.4%-16.5%
5Y-20.4%10Y-30.7%+10.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-36.4%-6.2%-30.2%
TTM-36.9%-5.8%-31.1%
YOY-24.0%4.8%-28.8%
5Y-20.4%1.6%-22.0%
10Y-30.7%-2.0%-28.7%
1.2.2. Operating Ratio

Measures how efficient Caredx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.36 means that the operating costs are $1.36 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Caredx Inc:

  • The MRQ is 1.364. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.372. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.364TTM1.372-0.008
TTM1.372YOY1.240+0.132
TTM1.3725Y1.201+0.171
5Y1.20110Y1.265-0.064
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3641.310+0.054
TTM1.3721.303+0.069
YOY1.2401.2400.000
5Y1.2011.270-0.069
10Y1.2651.228+0.037

1.3. Liquidity of Caredx Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Caredx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 4.02 means the company has $4.02 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Caredx Inc:

  • The MRQ is 4.018. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.696. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.018TTM4.696-0.677
TTM4.696YOY5.481-0.785
TTM4.6965Y4.818-0.122
5Y4.81810Y3.546+1.272
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0182.194+1.824
TTM4.6962.366+2.330
YOY5.4812.753+2.728
5Y4.8182.989+1.829
10Y3.5463.000+0.546
1.3.2. Quick Ratio

Measures if Caredx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Caredx to the Diagnostics & Research industry mean.
  • A Quick Ratio of 5.63 means the company can pay off $5.63 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Caredx Inc:

  • The MRQ is 5.632. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.882. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.632TTM6.882-1.250
TTM6.882YOY7.509-0.627
TTM6.8825Y5.641+1.242
5Y5.64110Y3.842+1.799
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ5.6321.273+4.359
TTM6.8821.355+5.527
YOY7.5091.563+5.946
5Y5.6411.952+3.689
10Y3.8422.127+1.715

1.4. Solvency of Caredx Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Caredx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Caredx to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.46 means that Caredx assets are financed with 46.1% credit (debt) and the remaining percentage (100% - 46.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Caredx Inc:

  • The MRQ is 0.461. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.273. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.461TTM0.273+0.188
TTM0.273YOY0.187+0.086
TTM0.2735Y0.240+0.033
5Y0.24010Y0.889-0.649
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4610.425+0.036
TTM0.2730.411-0.138
YOY0.1870.393-0.206
5Y0.2400.450-0.210
10Y0.8890.448+0.441
1.4.2. Debt to Equity Ratio

Measures if Caredx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Caredx to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 85.4% means that company has $0.85 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Caredx Inc:

  • The MRQ is 0.854. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.414. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.854TTM0.414+0.441
TTM0.414YOY0.231+0.183
TTM0.4145Y0.335+0.079
5Y0.33510Y0.797-0.462
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8540.606+0.248
TTM0.4140.571-0.157
YOY0.2310.606-0.375
5Y0.3350.637-0.302
10Y0.7970.730+0.067

2. Market Valuation of Caredx Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Caredx generates.

  • Above 15 is considered overpriced but always compare Caredx to the Diagnostics & Research industry mean.
  • A PE ratio of -1.36 means the investor is paying $-1.36 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Caredx Inc:

  • The EOD is -0.912. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.356. Based on the earnings, the company is expensive. -2
  • The TTM is -3.785. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.912MRQ-1.356+0.444
MRQ-1.356TTM-3.785+2.429
TTM-3.785YOY-14.974+11.189
TTM-3.7855Y-148.921+145.136
5Y-148.92110Y-84.490-64.431
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.912-0.202-0.710
MRQ-1.356-0.402-0.954
TTM-3.785-0.119-3.666
YOY-14.974-0.003-14.971
5Y-148.9212.211-151.132
10Y-84.4904.907-89.397
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Caredx Inc:

  • The EOD is -10.798. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -16.057. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -30.473. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.798MRQ-16.057+5.259
MRQ-16.057TTM-30.473+14.416
TTM-30.473YOY-5.509-24.964
TTM-30.4735Y117.897-148.370
5Y117.89710Y13.003+104.894
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-10.798-0.179-10.619
MRQ-16.057-0.417-15.640
TTM-30.473-1.288-29.185
YOY-5.509-2.547-2.962
5Y117.897-1.999+119.896
10Y13.003-2.372+15.375
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Caredx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 2.45 means the investor is paying $2.45 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Caredx Inc:

  • The EOD is 1.649. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.452. Based on the equity, the company is underpriced. +1
  • The TTM is 1.428. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.649MRQ2.452-0.803
MRQ2.452TTM1.428+1.024
TTM1.428YOY2.592-1.164
TTM1.4285Y7.255-5.828
5Y7.25510Y-21.003+28.258
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD1.6491.877-0.228
MRQ2.4522.437+0.015
TTM1.4282.235-0.807
YOY2.5923.239-0.647
5Y7.2553.450+3.805
10Y-21.0034.040-25.043
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Caredx Inc.

3.1. Institutions holding Caredx Inc

Institutions are holding 100.392% of the shares of Caredx Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31ARK Investment Management LLC13.89520.511171947225153997.7163
2023-12-31BlackRock Inc10.70650.001755436661648293.0644
2023-12-31Vanguard Group Inc7.95640.00114119682-18909-0.4569
2023-12-31Bellevue Group AG7.63790.72593954792139940.3551
2023-12-31Nikko Asset Management Americas Inc5.55230.33162874899-149604-4.9464
2023-12-31Sumitomo Mitsui Trust Holdings Inc5.55230.02552874899-149604-4.9464
2023-12-31State Street Corporation5.40040.00162796267-912881-24.6116
2023-09-30D. E. Shaw & Co LP4.48920.0172324432-111321-4.5703
2023-12-31Gagnon Securities LLC4.04816.03782096044209001.0072
2023-12-31Morgan Stanley - Brokerage Accounts3.0480.00171578228897839131.9597
2023-12-31Renaissance Technologies Corp2.63060.0253136210031580030.1825
2023-12-31Geode Capital Management, LLC2.23830.00151158956501414.522
2023-12-31Arnhold & S. Bleichroeder Advisers, LLC2.18470.0323113120712601812.5367
2023-09-30Jacobs Levy Equity Management, Inc.2.1710.0466112411443209062.4386
2023-12-31Dimensional Fund Advisors, Inc.2.00760.0036103952141761067.1495
2023-12-31Goldman Sachs Group Inc1.81210.00193828230381447.8848
2023-12-31Acadian Asset Management LLC1.60420.038683063038920888.1714
2023-12-31Kent Lake Capital LLC1.19412.8653618301-757157-55.0476
2023-12-31Bank of Montreal1.13080.0023585500362996163.1413
2023-12-31BMO Capital Markets Corp.1.13080.0023585500362996163.1413
Total 86.390510.673844731742+2274158+5.1%

3.2. Funds holding Caredx Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31ARK Genomic Revolution11.22153.82875810318-1321464-18.5292
2024-03-28ARK Genomic Revolution ETF11.19143.8304579473900
2023-11-30Bellevue Healthcare Ord7.4324.2485384817373640823.6653
2024-03-28SPDR® S&P Biotech ETF5.86970.42623039245383201.2769
2024-02-29Nikko AM ARK Pstv Chg Innovt P JPY Acc3.89830.85232018507-15175-0.7462
2024-02-29Vanguard Total Stock Mkt Idx Inv3.10470.0011160758000
2024-03-28iShares Russell 2000 ETF2.47860.020812833746180.0482
2023-12-31First Eagle US Small Cap Strategy1.99830.7353103470011438812.4293
2024-02-29First Eagle Small Cap Opportunity I1.85540.577496071400
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.58870.0086822619-143-0.0174
2024-02-29Vanguard Small Cap Index1.27880.00566211859290.9036
2024-01-31Fidelity Small Cap Index1.01950.018252786089841.7314
2024-03-28iShares Russell 2000 Value ETF0.95850.0419496290114872.3694
2024-03-28iShares Biotechnology ETF0.72160.051937364900
2024-02-29Vanguard Small Cap Growth Index Inv0.7180.011337178361931.694
2024-03-31Direxion Daily S&P Biotech Bull 3X ETF0.70450.3093364799-2559-0.6966
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.59680.007930899246001.5112
2024-02-29BlackRock Advantage Small Cap Core Instl0.59230.093306684-18646-5.7314
2024-02-29Fidelity Extended Market Index0.57490.0083297699-4283-1.4183
2024-03-29Dimensional US Targeted Value ETF0.53780.029427848100
Total 58.341315.105530208324-435343-1.4%

3.3. Insider Transactions

Insiders are holding 3.151% of the shares of Caredx Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-10-02Reginald SeetoSELL28186.91
2023-09-05Reginald SeetoSELL28199.49
2023-08-14Reginald SeetoSELL5768.89
2023-08-02Reginald SeetoSELL281911.35
2023-07-13Peter MaagSELL500010.34
2023-07-13Reginald SeetoSELL526010.33
2023-07-03Reginald SeetoSELL28188.48
2023-06-28Peter MaagSELL24328.72
2023-06-28Reginald SeetoSELL142688.76
2023-06-02Reginald SeetoSELL28198.13
2023-05-02Reginald SeetoSELL28198.12

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Caredx Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---2.380-0.789-67%-0.191-92%0.152-1665%0.195-1320%
Book Value Per Share--4.8956.881-29%8.294-41%6.088-20%3.168+55%
Current Ratio--4.0184.696-14%5.481-27%4.818-17%3.546+13%
Debt To Asset Ratio--0.4610.273+69%0.187+146%0.240+92%0.889-48%
Debt To Equity Ratio--0.8540.414+107%0.231+271%0.335+155%0.797+7%
Dividend Per Share----0%-0%0.011-100%0.018-100%
Eps---2.212-0.888-60%-0.359-84%-0.318-86%-0.234-89%
Free Cash Flow Per Share---0.187-0.128-31%-0.233+25%-0.094-50%-0.073-61%
Free Cash Flow To Equity Per Share---0.690-0.267-61%-0.254-63%0.211-428%0.143-583%
Gross Profit Margin--1.1691.700-31%2.256-48%4.374-73%11.015-89%
Intrinsic Value_10Y_max---5.357--------
Intrinsic Value_10Y_min---20.303--------
Intrinsic Value_1Y_max---0.328--------
Intrinsic Value_1Y_min---0.963--------
Intrinsic Value_3Y_max---1.145--------
Intrinsic Value_3Y_min---3.838--------
Intrinsic Value_5Y_max---2.154--------
Intrinsic Value_5Y_min---7.728--------
Market Cap417852495.000-53%640665960.000491977369.310+30%1156487014.385-45%1755253150.967-64%1059026077.921-40%
Net Profit Margin---1.801-0.703-61%-0.238-87%-0.266-85%-0.484-73%
Operating Margin---0.364-0.369+1%-0.240-34%-0.204-44%-0.307-16%
Operating Ratio--1.3641.372-1%1.240+10%1.201+14%1.265+8%
Pb Ratio1.649-49%2.4521.428+72%2.592-5%7.255-66%-21.003+957%
Pe Ratio-0.912+33%-1.356-3.785+179%-14.974+1004%-148.921+10881%-84.490+6130%
Price Per Share8.070-49%12.0009.160+31%21.725-45%33.567-64%20.287-41%
Price To Free Cash Flow Ratio-10.798+33%-16.057-30.473+90%-5.509-66%117.897-114%13.003-223%
Price To Total Gains Ratio-3.391+33%-5.042-25.568+407%-118.999+2260%-232.165+4504%-97.367+1831%
Quick Ratio--5.6326.882-18%7.509-25%5.6410%3.842+47%
Return On Assets---0.244-0.096-61%-0.035-86%-0.041-83%-0.075-69%
Return On Equity---0.452-0.157-65%-0.043-90%-0.060-87%-0.141-69%
Total Gains Per Share---2.380-0.789-67%-0.191-92%0.163-1558%0.213-1216%
Usd Book Value--261328000.000370174000.000-29%442170750.000-41%321629800.000-19%167241500.000+56%
Usd Book Value Change Per Share---2.380-0.789-67%-0.191-92%0.152-1665%0.195-1320%
Usd Book Value Per Share--4.8956.881-29%8.294-41%6.088-20%3.168+55%
Usd Dividend Per Share----0%-0%0.011-100%0.018-100%
Usd Eps---2.212-0.888-60%-0.359-84%-0.318-86%-0.234-89%
Usd Free Cash Flow---9975000.000-6907000.000-31%-12393250.000+24%-4990050.000-50%-3845450.000-61%
Usd Free Cash Flow Per Share---0.187-0.128-31%-0.233+25%-0.094-50%-0.073-61%
Usd Free Cash Flow To Equity Per Share---0.690-0.267-61%-0.254-63%0.211-428%0.143-583%
Usd Market Cap417852495.000-53%640665960.000491977369.310+30%1156487014.385-45%1755253150.967-64%1059026077.921-40%
Usd Price Per Share8.070-49%12.0009.160+31%21.725-45%33.567-64%20.287-41%
Usd Profit---118097000.000-47571000.000-60%-19153250.000-84%-16912050.000-86%-12566050.000-89%
Usd Revenue--65569000.00070081000.000-6%80448250.000-18%60888800.000+8%35950000.000+82%
Usd Total Gains Per Share---2.380-0.789-67%-0.191-92%0.163-1558%0.213-1216%
 EOD+3 -5MRQTTM+6 -28YOY+7 -275Y+5 -3110Y+10 -26

4.2. Fundamental Score

Let's check the fundamental score of Caredx Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.912
Price to Book Ratio (EOD)Between0-11.649
Net Profit Margin (MRQ)Greater than0-1.801
Operating Margin (MRQ)Greater than0-0.364
Quick Ratio (MRQ)Greater than15.632
Current Ratio (MRQ)Greater than14.018
Debt to Asset Ratio (MRQ)Less than10.461
Debt to Equity Ratio (MRQ)Less than10.854
Return on Equity (MRQ)Greater than0.15-0.452
Return on Assets (MRQ)Greater than0.05-0.244
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Caredx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.752
Ma 20Greater thanMa 509.421
Ma 50Greater thanMa 1009.646
Ma 100Greater thanMa 20010.021
OpenGreater thanClose8.300
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets484,615
Total Liabilities223,287
Total Stockholder Equity261,328
 As reported
Total Liabilities 223,287
Total Stockholder Equity+ 261,328
Total Assets = 484,615

Assets

Total Assets484,615
Total Current Assets313,713
Long-term Assets170,902
Total Current Assets
Cash And Cash Equivalents 82,197
Short-term Investments 153,221
Net Receivables 51,061
Inventory 19,471
Other Current Assets 7,763
Total Current Assets  (as reported)313,713
Total Current Assets  (calculated)313,713
+/-0
Long-term Assets
Property Plant Equipment 65,137
Goodwill 40,336
Intangible Assets 45,701
Long-term Assets Other 1,353
Long-term Assets  (as reported)170,902
Long-term Assets  (calculated)152,527
+/- 18,375

Liabilities & Shareholders' Equity

Total Current Liabilities78,072
Long-term Liabilities145,215
Total Stockholder Equity261,328
Total Current Liabilities
Short-term Debt 5,943
Accounts payable 12,872
Other Current Liabilities 54,509
Total Current Liabilities  (as reported)78,072
Total Current Liabilities  (calculated)73,324
+/- 4,748
Long-term Liabilities
Capital Lease Obligations 34,221
Long-term Liabilities Other 96,551
Long-term Liabilities  (as reported)145,215
Long-term Liabilities  (calculated)130,772
+/- 14,443
Total Stockholder Equity
Common Stock49
Retained Earnings -678,269
Accumulated Other Comprehensive Income -6,963
Other Stockholders Equity 946,511
Total Stockholder Equity (as reported)261,328
Total Stockholder Equity (calculated)261,328
+/-0
Other
Capital Stock49
Cash and Short Term Investments 235,418
Common Stock Shares Outstanding 53,389
Current Deferred Revenue4,748
Liabilities and Stockholders Equity 484,615
Net Debt -47,976
Net Invested Capital 261,328
Net Working Capital 235,641
Property Plant and Equipment Gross 97,400
Short Long Term Debt Total 34,221



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312007-09-302006-12-312005-12-31
> Total Assets 
26,912
23,138
29,237
9,876
0
0
0
9,873
11,095
33,997
62,862
61,141
63,277
61,366
59,342
55,638
48,834
100,164
102,092
76,730
76,730
77,738
75,093
83,565
78,952
79,879
91,446
130,697
127,859
142,907
144,833
151,736
156,784
344,742
353,552
368,511
541,223
557,415
563,172
566,621
546,711
541,288
544,511
542,991
528,217
514,820
501,180
484,615
484,615501,180514,820528,217542,991544,511541,288546,711566,621563,172557,415541,223368,511353,552344,742156,784151,736144,833142,907127,859130,69791,44679,87978,95283,56575,09377,73876,73076,730102,092100,16448,83455,63859,34261,36663,27761,14162,86233,99711,0959,8730009,87629,23723,13826,912
   > Total Current Assets 
0
0
0
0
0
0
0
8,171
9,480
13,530
42,011
40,346
42,301
40,005
37,969
34,362
27,666
32,661
35,123
26,673
26,673
19,909
16,946
26,767
32,697
30,577
41,943
81,114
77,578
68,324
68,124
71,922
66,068
251,547
258,659
273,097
438,701
440,996
444,675
433,360
411,487
403,880
388,157
387,849
371,428
360,814
345,166
313,713
313,713345,166360,814371,428387,849388,157403,880411,487433,360444,675440,996438,701273,097258,659251,54766,06871,92268,12468,32477,57881,11441,94330,57732,69726,76716,94619,90926,67326,67335,12332,66127,66634,36237,96940,00542,30140,34642,01113,5309,4808,1710000000
       Cash And Cash Equivalents 
0
0
0
5,830
0
0
0
5,128
4,837
7,872
39,048
36,431
38,985
36,894
33,954
29,888
23,752
17,144
22,265
17,258
17,258
9,104
5,976
16,895
18,695
16,246
26,202
64,616
57,432
43,469
40,927
38,223
32,191
211,409
213,798
134,669
309,324
335,625
353,082
348,485
171,892
166,832
82,959
89,921
74,660
87,786
75,980
82,197
82,19775,98087,78674,66089,92182,959166,832171,892348,485353,082335,625309,324134,669213,798211,40932,19138,22340,92743,46957,43264,61626,20216,24618,69516,8955,9769,10417,25817,25822,26517,14423,75229,88833,95436,89438,98536,43139,0487,8724,8375,1280005,830000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90,034
64,963
34,317
10,199
0
147,330
139,388
208,317
203,168
211,279
194,887
192,204
153,221
153,221192,204194,887211,279203,168208,317139,388147,330010,19934,31764,96390,03400000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
2,270
2,093
1,725
1,749
2,687
1,794
1,706
2,241
2,367
2,512
4,887
4,568
2,768
2,768
3,005
3,270
2,991
6,536
8,072
9,641
9,760
12,525
17,052
19,169
24,057
22,841
27,111
30,610
34,624
43,361
48,066
56,181
59,761
65,320
70,142
70,425
66,312
59,310
51,625
51,694
51,061
51,06151,69451,62559,31066,31270,42570,14265,32059,76156,18148,06643,36134,62430,61027,11122,84124,05719,16917,05212,5259,7609,6418,0726,5362,9913,2703,0052,7682,7684,5684,8872,5122,3672,2411,7061,7942,6871,7491,7252,0932,2700000000
       Other Current Assets 
208
383
477
248
0
0
0
255
1,825
3,319
718
542
747
674
960
1,341
807
1,779
846
1,186
1,186
1,457
1,530
1,352
2,455
1,593
1,479
1,795
2,444
2,462
2,126
3,628
4,089
4,286
4,345
3,758
7,332
7,928
6,413
7,928
8,733
8,657
8,370
9,216
8,161
7,676
7,310
7,763
7,7637,3107,6768,1619,2168,3708,6578,7337,9286,4137,9287,3323,7584,3454,2864,0893,6282,1262,4622,4441,7951,4791,5932,4551,3521,5301,4571,1861,1868461,7798071,3419606747475427183,3191,825255000248477383208
   > Long-term Assets 
0
0
0
0
0
0
0
1,702
1,615
20,467
20,851
20,795
20,976
21,361
21,373
21,276
21,168
67,503
66,969
50,057
50,057
57,829
58,147
56,798
46,255
49,302
49,503
49,583
50,281
74,583
76,709
79,814
90,716
93,195
94,893
95,414
102,522
116,419
118,497
133,261
135,224
137,408
156,354
155,142
156,789
154,006
156,014
170,902
170,902156,014154,006156,789155,142156,354137,408135,224133,261118,497116,419102,52295,41494,89393,19590,71679,81476,70974,58350,28149,58349,50349,30246,25556,79858,14757,82950,05750,05766,96967,50321,16821,27621,37321,36120,97620,79520,85120,4671,6151,7020000000
       Property Plant Equipment 
1,082
5,616
5,611
2,118
0
0
0
1,553
1,466
1,665
2,049
1,968
2,174
2,559
2,571
2,425
2,346
3,078
3,305
2,931
2,931
2,528
2,281
2,075
2,055
2,360
3,022
4,134
6,326
6,165
5,900
9,160
22,505
23,729
25,946
25,932
29,687
32,078
37,035
40,037
44,686
48,745
69,892
70,218
68,937
68,202
66,328
65,137
65,13766,32868,20268,93770,21869,89248,74544,68640,03737,03532,07829,68725,93225,94623,72922,5059,1605,9006,1656,3264,1343,0222,3602,0552,0752,2812,5282,9312,9313,3053,0782,3462,4252,5712,5592,1741,9682,0491,6651,4661,5530002,1185,6115,6161,082
       Goodwill 
0
0
0
0
0
0
0
0
0
12,005
12,005
12,005
12,005
12,005
12,005
12,005
12,005
27,918
28,047
13,839
13,839
12,005
12,005
12,005
12,005
12,005
12,005
12,005
12,005
22,559
23,777
23,857
23,857
23,857
23,857
23,857
26,109
26,051
26,051
36,983
36,983
37,084
37,523
37,523
39,615
39,655
40,208
40,336
40,33640,20839,65539,61537,52337,52337,08436,98336,98326,05126,05126,10923,85723,85723,85723,85723,85723,77722,55912,00512,00512,00512,00512,00512,00512,00512,00513,83913,83928,04727,91812,00512,00512,00512,00512,00512,00512,00512,005000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
6,650
6,650
6,650
6,650
6,650
6,650
6,650
6,650
36,344
35,444
33,124
33,124
33,743
34,307
33,139
31,989
34,760
34,284
33,252
31,759
45,604
45,781
45,541
43,112
44,356
43,830
44,355
45,457
48,432
48,367
50,195
48,149
46,318
43,855
43,051
45,637
43,529
46,455
45,701
45,70146,45543,52945,63743,05143,85546,31848,14950,19548,36748,43245,45744,35543,83044,35643,11245,54145,78145,60431,75933,25234,28434,76031,98933,13934,30733,74333,12433,12435,44436,3446,6506,6506,6506,6506,6506,6506,6506,650000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
149
149
147
147
172
147
147
147
196
167
163
173
163
163
9,553
9,554
9,579
206
177
192
192
191
255
1,251
1,256
1,242
1,253
1,260
1,270
1,269
9,858
7,044
6,046
5,406
5,261
5,084
-14,049
2,600
2,620
3,023
1,353
1,3533,0232,6202,600-14,0495,0845,2615,4066,0467,0449,8581,2691,2701,2601,2531,2421,2561,2512551911921921772069,5799,5549,5531631631731631671961471471471721471471491490000000
> Total Liabilities 
0
0
0
21,877
0
0
0
160,546
163,019
184,907
21,823
19,843
23,810
24,593
25,439
26,144
28,374
67,520
65,312
56,969
56,969
65,752
75,268
89,519
45,559
50,927
47,058
34,769
32,237
49,741
47,290
52,736
55,400
83,975
84,908
90,832
69,677
77,572
91,025
100,745
89,167
97,739
107,832
112,080
108,196
109,607
107,046
223,287
223,287107,046109,607108,196112,080107,83297,73989,167100,74591,02577,57269,67790,83284,90883,97555,40052,73647,29049,74132,23734,76947,05850,92745,55989,51975,26865,75256,96956,96965,31267,52028,37426,14425,43924,59323,81019,84321,823184,907163,019160,54600021,877000
   > Total Current Liabilities 
2,363
7,880
9,832
6,437
0
0
0
7,593
10,578
21,214
11,118
11,135
6,275
8,242
10,454
10,152
14,231
38,029
39,605
40,832
40,832
54,236
30,961
42,906
13,445
14,176
15,817
19,504
16,370
28,620
30,971
34,828
28,324
56,942
62,423
69,217
45,730
56,255
69,736
77,301
66,920
78,456
70,288
75,975
71,828
74,496
72,674
78,072
78,07272,67474,49671,82875,97570,28878,45666,92077,30169,73656,25545,73069,21762,42356,94228,32434,82830,97128,62016,37019,50415,81714,17613,44542,90630,96154,23640,83240,83239,60538,02914,23110,15210,4548,2426,27511,13511,11821,21410,5787,5930006,4379,8327,8802,363
       Short-term Debt 
0
0
0
0
0
0
0
4,504
5,523
10,434
5,798
5,961
1,120
2,380
3,670
2,866
4,482
18,824
17,902
22,846
22,846
33,927
15,030
15,721
536
139
169
172
2,040
2,034
2,033
3,017
1,570
1,733
1,872
2,033
3,126
3,363
3,822
3,958
3,697
2,989
5,213
5,591
5,738
5,809
5,958
5,943
5,9435,9585,8095,7385,5915,2132,9893,6973,9583,8223,3633,1262,0331,8721,7331,5703,0172,0332,0342,04017216913953615,72115,03033,92722,84622,84617,90218,8244,4822,8663,6702,3801,1205,9615,79810,4345,5234,5040000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
5,961
0
0
0
2,866
0
0
0
22,846
33,896
33,941
15,000
15,721
461
13,786
0
0
1,866
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000001,8660013,78646115,72115,00033,94133,89622,8460002,8660005,96100000000000
       Accounts payable 
675
1,990
2,435
637
0
0
0
618
781
1,741
1,036
1,128
1,371
1,203
1,949
1,644
2,536
3,339
3,464
12,499
3,065
3,599
3,396
3,391
4,269
3,480
2,676
4,711
3,859
7,380
5,691
5,506
6,621
8,675
9,519
9,653
11,597
12,563
14,894
13,337
10,605
16,892
10,625
9,942
12,861
9,880
8,972
12,872
12,8728,9729,88012,8619,94210,62516,89210,60513,33714,89412,56311,5979,6539,5198,6756,6215,5065,6917,3803,8594,7112,6763,4804,2693,3913,3963,5993,06512,4993,4643,3392,5361,6441,9491,2031,3711,1281,0361,7417816180006372,4351,990675
       Other Current Liabilities 
1,527
1,918
3,154
4,287
0
0
0
2,391
4,209
8,365
3,611
3,541
3,296
4,159
4,699
5,500
7,076
15,801
18,181
5,487
14,879
16,671
12,496
23,755
8,544
10,518
12,933
14,582
10,359
15,582
20,057
22,619
16,651
22,307
27,323
37,035
27,485
36,413
47,611
55,798
48,677
54,280
49,535
55,100
47,388
52,749
51,978
54,509
54,50951,97852,74947,38855,10049,53554,28048,67755,79847,61136,41327,48537,03527,32322,30716,65122,61920,05715,58210,35914,58212,93310,5188,54423,75512,49616,67114,8795,48718,18115,8017,0765,5004,6994,1593,2963,5413,6118,3654,2092,3910004,2873,1541,9181,527
   > Long-term Liabilities 
0
0
0
0
0
0
0
152,953
152,441
163,693
10,705
8,708
17,535
16,351
14,985
15,992
14,143
29,491
25,707
16,137
16,137
11,516
44,307
46,613
32,114
36,751
31,241
15,265
15,867
21,121
16,319
17,908
27,076
27,033
22,485
21,615
23,947
21,317
21,289
23,444
22,247
19,283
37,544
36,105
36,368
35,111
34,372
145,215
145,21534,37235,11136,36836,10537,54419,28322,24723,44421,28921,31723,94721,61522,48527,03327,07617,90816,31921,12115,86715,26531,24136,75132,11446,61344,30711,51616,13716,13725,70729,49114,14315,99214,98516,35117,5358,70810,705163,693152,441152,9530000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
8,338
6,930
5,451
14,609
13,389
12,125
12,887
11,368
10,072
8,496
1,098
0
0
21,174
18,338
9,729
13,337
13,384
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000013,38413,3379,72918,33821,174001,0988,49610,07211,36812,88712,12513,38914,6095,4516,9308,338000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
-4,504
-5,523
-10,434
-5,798
-5,961
-1,120
-2,380
-3,670
-2,866
-4,482
-18,824
-17,902
-22,846
-22,846
-33,927
-15,030
-15,721
-536
-139
-169
-172
0
0
0
0
17,503
17,025
16,539
14,036
18,462
17,783
17,876
17,394
16,729
16,065
34,708
33,406
26,268
30,589
29,252
28,278
28,27829,25230,58926,26833,40634,70816,06516,72917,39417,87617,78318,46214,03616,53917,02517,5030000-172-169-139-536-15,721-15,030-33,927-22,846-22,846-17,902-18,824-4,482-2,866-3,670-2,380-1,120-5,961-5,798-10,434-5,523-4,5040000000
       Warrants
0
0
0
0
0
0
0
0
0
149,444
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000149,444000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
3,121
1,037
1,102
849
991
646
976
735
9,621
8,381
6,922
4,560
3,759
15,425
21,699
16,447
18,324
13,130
11,136
13,296
18,811
14,306
15,935
25,574
25,720
21,298
20,316
23,002
473
456
23,029
22,053
19,258
37,531
249
36,368
35,060
245
96,551
96,55124535,06036,36824937,53119,25822,05323,02945647323,00220,31621,29825,72025,57415,93514,30618,81113,29611,13613,13018,32416,44721,69915,4253,7594,5606,9228,3819,6217359766469918491,1021,0373,121000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
2,790
2,738
2,155
2,077
1,971
2,214
2,129
2,040
10,004
8,830
8,117
7,899
7,757
7,708
6,576
5,938
5,090
4,727
4,129
2,571
2,310
2,013
1,973
1,502
1,313
1,187
1,299
945
810
678
415
194
25
13
0
0
51
0
0
00510013251944156788109451,2991,1871,3131,5021,9732,0132,3102,5714,1294,7275,0905,9386,5767,7087,7577,8998,1178,83010,0042,0402,1292,2141,9712,0772,1552,7382,790000000000
> Total Stockholder Equity
0
0
0
0
0
0
0
-150,673
-151,924
-150,910
41,039
41,298
39,467
36,773
33,903
29,494
20,460
32,033
36,206
19,482
19,482
11,831
-311
-6,134
33,393
28,952
44,388
95,928
95,622
93,166
97,543
99,000
101,384
260,767
268,644
277,679
471,546
479,843
472,147
465,876
457,544
443,549
436,679
430,911
420,021
405,213
394,134
261,328
261,328394,134405,213420,021430,911436,679443,549457,544465,876472,147479,843471,546277,679268,644260,767101,38499,00097,54393,16695,62295,92844,38828,95233,393-6,134-31111,83119,48219,48236,20632,03320,46029,49433,90336,77339,46741,29841,039-150,910-151,924-150,6730000000
   Retained Earnings -678,269-534,202-509,903-484,883-460,444-441,473-424,534-402,837-383,189-367,038-355,141-353,214-352,527-349,012-346,194-339,636-333,813-329,036-327,223-319,376-311,845-308,090-288,120-274,058-268,022-236,351-222,083-212,553-212,553-197,071-193,171-182,836-173,082-168,322-164,834-161,649-159,375-159,370-160,583-161,460-160,1560000000
   Accumulated Other Comprehensive Income -6,963-8,670-8,450-7,439-7,503-8,809-7,182-5,090-4,670-4,093-3,156-3,599-2,096-4,352-5,314-6,910-5,205-5,934-5,071-5,002-4,278-3,988-4,108-2,482-2,345-2,198-2,724-3,659-4,000-1,831-1,408-11,873-11,87300-11,092-11,092-62,862-8080-10,9020000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
9,672
200,397
200,661
201,104
201,595
202,213
202,564
203,284
226,593
235,087
235,673
236,122
236,617
238,215
264,204
309,898
321,144
356,427
412,010
419,959
425,418
432,471
437,976
447,888
612,228
621,961
632,253
828,308
838,089
843,226
853,683
865,419
875,213
886,909
0
912,291
923,514
0
0
00923,514912,2910886,909875,213865,419853,683843,226838,089828,308632,253621,961612,228447,888437,976432,471425,418419,959412,010356,427321,144309,898264,204238,215236,617236,122235,673235,087226,593203,284202,564202,213201,595201,104200,661200,3979,672000000000
   Treasury Stock000000000000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue280,324
Cost of Revenue-104,456
Gross Profit175,868175,868
 
Operating Income (+$)
Gross Profit175,868
Operating Expense-277,768
Operating Income-101,900-101,900
 
Operating Expense (+$)
Research Development81,866
Selling General Administrative117,868
Selling And Marketing Expenses83,334
Operating Expense277,768283,068
 
Net Interest Income (+$)
Interest Income11,867
Interest Expense-0
Other Finance Cost-0
Net Interest Income11,867
 
Pretax Income (+$)
Operating Income-101,900
Net Interest Income11,867
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-190,143-13,657
EBIT - interestExpense = -101,900
-190,143
-190,284
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-101,900-190,143
Earnings Before Interest and Taxes (EBITDA)-82,076
 
After tax Income (+$)
Income Before Tax-190,143
Tax Provision-141
Net Income From Continuing Ops-190,284-190,284
Net Income-190,284
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses382,224
Total Other Income/Expenses Net-88,243-11,867
 

Technical Analysis of Caredx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Caredx. The general trend of Caredx is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Caredx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Caredx Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 9.38 < 11.10 < 12.68.

The bearish price targets are: 7.83 > 4.8.

Tweet this
Caredx Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Caredx Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Caredx Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Caredx Inc. The current macd is -0.51076026.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Caredx price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Caredx. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Caredx price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Caredx Inc Daily Moving Average Convergence/Divergence (MACD) ChartCaredx Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Caredx Inc. The current adx is 16.57.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Caredx shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Caredx Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Caredx Inc. The current sar is 9.74458109.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Caredx Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Caredx Inc. The current rsi is 34.75. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Caredx Inc Daily Relative Strength Index (RSI) ChartCaredx Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Caredx Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Caredx price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Caredx Inc Daily Stochastic Oscillator ChartCaredx Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Caredx Inc. The current cci is -129.72426516.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Caredx Inc Daily Commodity Channel Index (CCI) ChartCaredx Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Caredx Inc. The current cmo is -38.72128602.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Caredx Inc Daily Chande Momentum Oscillator (CMO) ChartCaredx Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Caredx Inc. The current willr is -91.98606272.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Caredx Inc Daily Williams %R ChartCaredx Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Caredx Inc.

Caredx Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Caredx Inc. The current atr is 0.5946734.

Caredx Inc Daily Average True Range (ATR) ChartCaredx Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Caredx Inc. The current obv is -19,231,396.

Caredx Inc Daily On-Balance Volume (OBV) ChartCaredx Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Caredx Inc. The current mfi is 38.98.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Caredx Inc Daily Money Flow Index (MFI) ChartCaredx Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Caredx Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Caredx Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Caredx Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.752
Ma 20Greater thanMa 509.421
Ma 50Greater thanMa 1009.646
Ma 100Greater thanMa 20010.021
OpenGreater thanClose8.300
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Caredx with someone you think should read this too:
  • Are you bullish or bearish on Caredx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Caredx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Caredx Inc

I send you an email if I find something interesting about Caredx Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Caredx Inc.

Receive notifications about Caredx Inc in your mailbox!